Search in:

Advanced search

International Journal of Chronic Obstructive Pulmonary Disease Volume 12, 2017 - Issue

Submit an article Journal homepage

Open access

127

Views

CrossRef citations to date

Altmetric

Original Research

Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD

Yueh Lan Huang1 Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City

Chih-Cheng Lai2 Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Tainan

Ya-Hui Wang3 Medical Research Center, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City

Cheng-Yi Wang1 Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei CityCorrespondence[email protected]

Jen-Yu Wang1 Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City

Hao-Chien Wang4 Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, TaipeiCorrespondence[email protected]

Chong-Jen Yu4 Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei

Likwang Chen5 Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Miaoli County, Taiwan

show all

Pages 2987-2996 | Published online: 11 Oct 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

SorianoJBVisickGTMuellerovaHPayvandiNHansellALPatterns of comorbidities in newly diagnosed COPD and asthma in primary careChest200512842099210716236861
PubMed Web of Science ®Google Scholar
FabbriLMLuppiFBeghéBRabeKFComplex chronic comorbidities of COPDEur Respir J200831120418166598
PubMed Web of Science ®Google Scholar
García-OlmosLAlberquillaÁAyalaVComorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional studyBMC Fam Pract2013141123324308
PubMed Web of Science ®Google Scholar
FearyJRRodriguesLCSmithCJHubbardRBGibsonJEPrevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary careThorax2010651195696220871122
PubMed Web of Science ®Google Scholar
GottliebSSMcCarterRJVogelRAEffect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarctionN Engl J Med199833984894979709041
PubMed Web of Science ®Google Scholar
ChenJRadfordMJWangYMarciniakTAKrumholzHMEffectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthmaJ Am Coll Cardiol20013771950195611401137
PubMed Web of Science ®Google Scholar
SmithSCBlairSNBonowROAHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardio-vascular disease: 2001 update a statement for healthcare professionals from the American Heart Association and the American College of CardiologyCirculation20011041577157911571256
PubMed Web of Science ®Google Scholar
SmithSCAllenJBlairSNAHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the national heart, lung, and blood instituteJ Am Coll Cardiol2006472130213916697342
PubMed Web of Science ®Google Scholar
DoughtyRNRodgersASharpeNMacMahonSEffects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trialsEur Heart J19971845605659129883
PubMed Web of Science ®Google Scholar
HurstJRVestboJAnzuetoAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
PubMed Web of Science ®Google Scholar
SalpeterSROrmistonTMSalpeterEECardioselective beta-blockers in patients with reactive airway disease: a meta-analysisAnn Intern Med2002137971572512416945
PubMed Web of Science ®Google Scholar
DransfieldMTRoweSMJohnsonJEBaileyWCGeraldLBUse of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPDThorax200863430130517951276
PubMed Web of Science ®Google Scholar
AuDHBrysonCLFanVSBeta-blockers as single-agent therapy for hypertension and the risk of mortality among patients with chronic obstructive pulmonary diseaseAm J Med20041171292593115629731
PubMed Web of Science ®Google Scholar
ShortPMLipworthSIElderDHSchembriSLipworthBJEffect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort studyBMJ2011342d254921558357
PubMed Web of Science ®Google Scholar
RuttenFHZuithoffNPHakEGrobbeeDEHoesAWBeta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary diseaseArch Intern Med20101701088088720498416
PubMed Web of Science ®Google Scholar
DuQSunYDingNLuLChenYBeta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studiesPLoS One2014911e11304825427000
PubMed Web of Science ®Google Scholar
VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
PubMed Web of Science ®Google Scholar
WangCYLaiCCYangWCThe association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) studyInt J Chron Obstruct Pulmon Dis2016112775278327877031
PubMed Web of Science ®Google Scholar
MatthewsRBrillISAS^® programs to select controls for matched case-control studiesSAS User Group ProceedingsBirmingham, ALUniversity of Alabama at Birmingham200530152230
Google Scholar
NiYShiGWanHUse of cardioselective beta-blockers in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized, placebo-controlled, blinded trialsJ Int Med Res20124062051206523321161
PubMed Web of Science ®Google Scholar
SalpeterSOrmistonTSalpeterECardioselective beta-blockers for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20054CD003566
Google Scholar
MikiATanakaYOhtaniHSawadaYBetaxolol-induced deterioration of asthma and a pharmacodynamic analysis based on beta-receptor occupancyInt J Clin Pharmacol Ther200341835836412940593
PubMed Web of Science ®Google Scholar
OfnerSSmithTJBetaxolol in chronic obstructive pulmonary diseaseJ Ocul Pharmacol1987321711762903205
PubMedGoogle Scholar
AnavekarSNBarterCAdamWRDoyleAEA double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways diseaseJ Cardiovasc Pharmacol19824suppl 3S374S3776184571
PubMed Web of Science ®Google Scholar
van der WoudeHJZaagsmaJPostmaDSWinterTHvan HulstMAalbersRDetrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockersChest2005127381882415764762
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date